Trillium Therapeutics Inc. (TRIL) Dipped -14.09% or -0.21 To Price $1.28 On Thursday


Trillium Therapeutics Inc. (TRIL) dipped -14.09% or -0.21 to $1.28. It is around 419653 shares traded, which is 166.22% compare to the average total volume 252461. The market cap of TRIL is $18.80 million. The year to date change is -37.29%. The 52 week price range is from $1.22 to $8.4. Price of TRIL have changed -17.36% during last week. It have changed -25.50% over last month, -53.44% over last 3 months, -69.59% over last 6 months and -79.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 1.97. It is 53.91% above current price. The 200-day Moving Averages for TRIL is 4.51. It is 252.34% above current price. The 52-week High is 8.4. It is 556.25% from the current price. The 52-week Low is 1.22. It is -4.69% from current price.

There are some statistics of TRIL. It is has market cap $18.80 million. The share outstanding is 14.69 million. The average volume is 252461. The percent of top 15 Institution holding is 49.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -627.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -62.50%.


Tags:

Share this post